Paper
8 January 2024 Application of stem cells and ketogenic diet therapies for Alzheimer’s disease
Wanjing Wang
Author Affiliations +
Proceedings Volume 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023); 129241Q (2024) https://doi.org/10.1117/12.3013021
Event: 3rd International Conference on Biological Engineering and Medical Science (ICBioMed2023), 2023, ONLINE, United Kingdom
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder primarily affecting elderly individuals. It is the most common form of dementia, characterized by cognitive decline, memory loss, and behavioral changes. Despite extensive research, a cure for the AD is yet to be discovered. Current treatments for AD are primarily symptomatic and targeted at delaying AD development. A comprehensive summary of two leading and promising treatments in various options available for AD will be presented in this research, including stem cell therapy and the ketogenic diet therapy. And this research will discuss these treatments' underlying mechanisms, effectiveness, and potential adverse effects. Finally, this research will highlight the challenges and future directions in developing effective treatments for the AD. This research intends to provide the latest summary of the AD treatment's current status and the progress toward finding a cure for this devastating disease.
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Wanjing Wang "Application of stem cells and ketogenic diet therapies for Alzheimer’s disease", Proc. SPIE 12924, Third International Conference on Biological Engineering and Medical Science (ICBioMed2023), 129241Q (8 January 2024); https://doi.org/10.1117/12.3013021
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
Back to Top